LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Home・Stock List・ADMA Biologics Inc

ADMA Biologics Inc

Closed

Sector Healthcare

16.71 1.58

Buy Sell

Overview

Share price change

24h

Current

Min

16.16

Max

16.74

Key metrics
By Trading Economics
Income	35M 18M
Sales	8M 82M
EPS	0.08
Profit margin	21.748
Employees	624
EBITDA	7.9M 24M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+20.18 upside

Dividends
By Dow Jones
Next Earnings	6 Nov 2024

Market Stats
By TradingEconomics
Market Cap	-671M 3.8B
Previous open	15.13
Previous close	16.71

News Sentiment

By Acuity

80%

20%

372 / 389 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

15.75 / 16.82 Support & Resistance

ADMA Biologics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

28 Oct 2024, 23:02 UTC

Peer Comparison

Price change

ADMA Biologics Inc Forecast

Price Target

By TipRanks

20.18% upside

12 Months Forecast

Average 19 USD 20.18%

High 20 USD

Low 18 USD

Based on 3 Wall Street analysts offering 12 month price targets forADMA Biologics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to ADMA Biologics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

15.75 / 16.82Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

There is one bullish event.

Sentiment

By Acuity

372 / 389 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About ADMA Biologics Inc

ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include ADMA BioManufacturing and Plasma Collection Centers. The Company’s ADMA BioManufacturing segment reflects its immune globulin manufacturing and development operations in Florida. The Plasma Collection Centers segment consists of approximately three plasma collection facilities. Its products include BIVIGAM, ASCENIV and Nabi-HB. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons.